Veradigm Debt to Equity Ratio 2010-2022 | MDRX
Veradigm Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2022-12-31 | $0.49B | $1.02B | 0.48 |
2022-09-30 | $0.51B | $1.18B | 0.44 |
2022-06-30 | $0.52B | $1.20B | 0.43 |
2022-03-31 | $1.08B | $1.35B | 0.80 |
2021-12-31 | $0.95B | $1.36B | 0.70 |
2021-09-30 | $1.07B | $1.42B | 0.75 |
2021-06-30 | $1.15B | $1.39B | 0.82 |
2021-03-31 | $1.19B | $1.68B | 0.71 |
2020-12-31 | $1.25B | $1.67B | 0.75 |
2020-09-30 | $1.94B | $1.21B | 1.60 |
2020-06-30 | $1.95B | $1.24B | 1.57 |
2020-03-31 | $2.01B | $1.24B | 1.62 |
2019-12-31 | $1.92B | $1.29B | 1.49 |
2019-09-30 | $1.95B | $1.28B | 1.52 |
2019-06-30 | $1.92B | $1.32B | 1.46 |
2019-03-31 | $1.79B | $1.46B | 1.23 |
2018-12-31 | $1.60B | $1.58B | 1.01 |
2018-09-30 | $3.40B | $1.12B | 3.05 |
2018-06-30 | $3.21B | $1.14B | 2.81 |
2018-03-31 | $3.26B | $1.11B | 2.94 |
2017-12-31 | $3.07B | $1.16B | 2.65 |
2017-09-30 | $2.74B | $1.15B | 2.39 |
2017-06-30 | $2.62B | $1.17B | 2.25 |
2017-03-31 | $2.61B | $1.19B | 2.20 |
2016-12-31 | $2.56B | $1.27B | 2.01 |
2016-09-30 | $2.44B | $1.37B | 1.78 |
2016-06-30 | $2.36B | $1.35B | 1.75 |
2016-03-31 | $1.24B | $1.39B | 0.89 |
2015-12-31 | $1.26B | $1.42B | 0.89 |
2015-09-30 | $1.28B | $1.40B | 0.92 |
2015-06-30 | $1.31B | $1.39B | 0.94 |
2015-03-31 | $1.23B | $1.28B | 0.96 |
2014-12-31 | $1.18B | $1.28B | 0.92 |
2014-09-30 | $1.29B | $1.28B | 1.00 |
2014-06-30 | $1.29B | $1.30B | 1.00 |
2014-03-31 | $1.33B | $1.31B | 1.02 |
2013-12-31 | $1.30B | $1.32B | 0.99 |
2013-09-30 | $1.31B | $1.33B | 0.98 |
2013-06-30 | $1.31B | $1.37B | 0.96 |
2013-03-31 | $1.29B | $1.33B | 0.97 |
2012-12-31 | $1.07B | $1.28B | 0.83 |
2012-09-30 | $1.11B | $1.30B | 0.85 |
2012-06-30 | $1.20B | $1.28B | 0.94 |
2012-03-31 | $1.06B | $1.49B | 0.71 |
2011-12-31 | $1.03B | $1.48B | 0.70 |
2011-09-30 | $0.99B | $1.44B | 0.69 |
2011-06-30 | $1.04B | $1.41B | 0.74 |
2011-03-31 | $1.02B | $1.43B | 0.71 |
2010-12-31 | $1.04B | $1.38B | 0.75 |
2010-09-30 | $1.01B | $1.37B | 0.74 |
2010-06-30 | $0.00B | 0.00 | |
2010-05-31 | $0.29B | $0.81B | 0.36 |
2010-03-31 | $0.00B | 0.00 | |
2010-02-28 | $0.24B | $0.79B | 0.31 |
2009-12-31 | $0.21B | $0.77B | 0.27 |
2009-11-30 | $0.21B | $0.77B | 0.27 |
2009-09-30 | $0.00B | 0.00 | |
2009-08-31 | $0.23B | $0.74B | 0.31 |
2009-05-31 | $0.25B | $0.70B | 0.36 |
2009-02-28 | $0.26B | $0.72B | 0.36 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.498B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $45.919B | 58.42 |
Doximity (DOCS) | United States | $11.317B | 52.39 |
Hims & Hers Health (HIMS) | United States | $10.654B | 110.70 |
Tempus AI (TEM) | United States | $10.042B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.327B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.691B | 57.67 |
Hinge Health (HNGE) | United States | $3.687B | 0.00 |
Privia Health (PRVA) | United States | $2.458B | 168.00 |
Schrodinger (SDGR) | United States | $1.674B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.583B | 0.00 |
Phreesia (PHR) | United States | $1.580B | 0.00 |
Enovis (ENOV) | United States | $1.502B | 8.38 |
Azenta (AZTA) | United States | $1.434B | 66.64 |
10x Genomics (TXG) | United States | $1.421B | 0.00 |
Omnicell (OMCL) | United States | $1.313B | 23.17 |
Evolent Health (EVH) | United States | $1.146B | 97.60 |
Claritev (CTEV) | United States | $0.705B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.540B | 0.00 |
Standard BioTools (LAB) | United States | $0.479B | 0.00 |
Butterfly Network (BFLY) | United States | $0.465B | 0.00 |
Talkspace (TALK) | United States | $0.427B | 127.50 |
TruBridge (TBRG) | United States | $0.337B | 746.67 |
Outset Medical (OM) | United States | $0.310B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
CapsoVision (CV) | United States | $0.206B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.187B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.160B | 0.00 |
Pulmonx (LUNG) | United States | $0.128B | 0.00 |
American Well (AMWL) | United States | $0.125B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.115B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.100B | 3.81 |
Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
111 (YI) | China | $0.066B | 0.00 |
P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
HeartBeam (BEAT) | United States | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.027B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.021B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |